GRP
BBIO icon

Global Retirement Partners’s BridgeBio Pharma BBIO Stock Holding History

Global Retirement Partners’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.1K Buy
+1,277
New +$89.4K ﹤0.01% 2107
2025
Q4 		$38.9K Buy
509
+372
+272% +$24.4K ﹤0.01% 2501
2025
Q3 		$7.12K Hold
137
– – ﹤0.01% 2836
2025
Q2 		$5.92K Buy
+137
New +$4.98K ﹤0.01% 2835
2024
Q4 		$3.98K Sell
145
-1,539
-91% -$39.8K ﹤0.01% 2788
2024
Q3 		$42.9K Sell
1,684
-654
-28% -$17.2K ﹤0.01% 1630
2024
Q2 		$59.2K Buy
2,338
+2,238
+2,238% +$61.2K ﹤0.01% 1450
2024
Q1 		$3.09K Sell
100
-200
-67% -$6.8K ﹤0.01% 2580
2023
Q4 		$11.3K Buy
300
+200
+200% +$6.01K ﹤0.01% 2027
2023
Q3 		$2.4K Hold
100
– – ﹤0.01% 2468
2023
Q2 		$1.72K Hold
100
– – ﹤0.01% 2598
2023
Q1 		$1.44K Hold
100
– – ﹤0.01% 2610
2022
Q4 		$762 Hold
100
– – ﹤0.01% 2662
2022
Q3 		$1K Hold
100
– – ﹤0.01% 2382
2022
Q2 		$1K Hold
100
– – ﹤0.01% 2352
2022
Q1 		$1K Buy
+100
New +$1.03K ﹤0.01% 2314
2021
Q4 		– Sell
-100
Closed -$5K – 376
2021
Q3 		$5K Hold
100
– – ﹤0.01% 1596
2021
Q2 		$6K Hold
100
– – ﹤0.01% 1509
2021
Q1 		$6K Buy
+100
New +$6.54K ﹤0.01% 1414

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Global Retirement Partners's BBIO Position: Q2 2026 in Review

Global Retirement Partners opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 1,277 shares worth $95.1K. The stake represents ﹤0.01% of the portfolio and ranks #2107 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in BBIO as recently as Q4 2025.

Global Retirement Partners first reported a position in BBIO in Q1 2021 and has held it in 19 quarters since. 475 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Global Retirement Partners held 1,277 shares of BridgeBio Pharma worth $95.1K as of Q2 2026.
  • BridgeBio Pharma was a new Global Retirement Partners position in Q2 2026.
  • BridgeBio Pharma made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2107 holding.
  • Global Retirement Partners first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 19 quarters since.
  • 475 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.